231 related articles for article (PubMed ID: 35219244)
1. Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment.
Conte P; Ascierto PA; Patelli G; Danesi R; Vanzulli A; Sandomenico F; Tarsia P; Cattelan A; Comes A; De Laurentiis M; Falcone A; Regge D; Richeldi L; Siena S
ESMO Open; 2022 Apr; 7(2):100404. PubMed ID: 35219244
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature.
Ishimoto H; Sakamoto N; Kido T; Ozasa M; Tsutsui S; Mori M; Setoguchi D; Takemoto S; Obase Y; Ishimatsu Y; Tomonaga C; Matsumoto K; Morisaki S; Miura K; Mukae H
BMC Pulm Med; 2023 Aug; 23(1):289. PubMed ID: 37553592
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy.
Kitahara Y; Inoue Y; Yasui H; Karayama M; Suzuki Y; Hozumi H; Furuhashi K; Enomoto N; Fujisawa T; Funai K; Honda T; Misawa K; Miyake H; Takeuchi H; Inui N; Suda T
Respir Res; 2024 Jan; 25(1):25. PubMed ID: 38200501
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease caused by niraparib in ovarian cancer patient: a case report and literature review.
Shono M; Murakami K; Ohta M; Nakai H; Matsumura N
Jpn J Clin Oncol; 2024 Mar; 54(3):352-356. PubMed ID: 38109478
[TBL] [Abstract][Full Text] [Related]
5. Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease.
Udagawa C; Horinouchi H; Shiraishi K; Kohno T; Okusaka T; Ueno H; Tamura K; Ohe Y; Zembutsu H
PLoS One; 2019; 14(10):e0223371. PubMed ID: 31584970
[TBL] [Abstract][Full Text] [Related]
6. Drug-Induced Interstitial Lung Disease: A Systematic Review.
Skeoch S; Weatherley N; Swift AJ; Oldroyd A; Johns C; Hayton C; Giollo A; Wild JM; Waterton JC; Buch M; Linton K; Bruce IN; Leonard C; Bianchi S; Chaudhuri N
J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30326612
[TBL] [Abstract][Full Text] [Related]
7. Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database.
Oura K; Tanaka M; Matsumoto K; Satake R; Inoue M; Yoshida Y; Wakabayashi W; Hasegawa S; Iwata M; Suzuki T; Maezawa M; Nakao S; Liao J; Iguchi K; Nakamura M
BMC Complement Med Ther; 2024 Mar; 24(1):121. PubMed ID: 38486172
[TBL] [Abstract][Full Text] [Related]
8. [Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):827-833. PubMed ID: 32992435
[TBL] [Abstract][Full Text] [Related]
9. Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin.
Mahmutovic Persson I; Falk Håkansson H; Örbom A; Liu J; von Wachenfeldt K; Olsson LE
Front Physiol; 2020; 11():584. PubMed ID: 32636756
[TBL] [Abstract][Full Text] [Related]
10. Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer.
Hackshaw MD; Danysh HE; Singh J; Ritchey ME; Ladner A; Taitt C; Camidge DR; Iwata H; Powell CA
Breast Cancer Res Treat; 2020 Aug; 183(1):23-39. PubMed ID: 32591987
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic approach of fibrosing interstitial lung diseases of unknown origin.
Cottin V; Valenzuela C
Presse Med; 2020 Jun; 49(2):104021. PubMed ID: 32437843
[TBL] [Abstract][Full Text] [Related]
12. [Drug-induced interstitial lung diseases].
Bonniaud P; Georges M; Favrolt N; Camus P
Rev Prat; 2014 Sep; 64(7):951-6. PubMed ID: 25362778
[TBL] [Abstract][Full Text] [Related]
13. Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease.
Dai HP; Ma F; Ren YH; Chen SS; Li YQ
Curr Med Sci; 2023 Feb; 43(1):1-12. PubMed ID: 36867358
[TBL] [Abstract][Full Text] [Related]
14. Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.
Mizuno R; Asano K; Mikami S; Nagata H; Kaneko G; Oya M
Jpn J Clin Oncol; 2012 May; 42(5):442-6. PubMed ID: 22438405
[TBL] [Abstract][Full Text] [Related]
15. [Interstitial lung disease associated with chemotherapy and molecularly-targeted drug: diagnosis and management].
Saito Y; Gemma A
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2531-7. PubMed ID: 22189216
[TBL] [Abstract][Full Text] [Related]
16. [Drug-induced interstitial lung diseases].
Bittmann I
Pathologe; 2021 Feb; 42(1):11-16. PubMed ID: 33415347
[TBL] [Abstract][Full Text] [Related]
17. [Diffuse idiopathic interstitial pneumonias. International multidisciplinary consensus classification by the American Thoracic Society and the European Respiratory Society, principal clinico-pathological entities, and diagnosis].
Cottin V; Capron F; Grenier P; Cordier JF
Rev Mal Respir; 2004 Apr; 21(2 Pt 1):299-318. PubMed ID: 15211238
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccine induced interstitial lung disease.
Yoshifuji A; Ishioka K; Masuzawa Y; Suda S; Murata S; Uwamino Y; Fujino M; Miyahara H; Hasegawa N; Ryuzaki M; Hoshino H; Sekine K
J Infect Chemother; 2022 Jan; 28(1):95-98. PubMed ID: 34580010
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.
Willemsen AE; Grutters JC; Gerritsen WR; van Erp NP; van Herpen CM; Tol J
Int J Cancer; 2016 May; 138(10):2312-21. PubMed ID: 26452336
[TBL] [Abstract][Full Text] [Related]
20. [Expert consensus on the diagnosis and treatment of anticancer drug-induced interstitial lung disease].
Anticancer Drug-induced Interstitial Lung Disease Management Group
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):693-702. PubMed ID: 35880334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
